Federal Register / Vol. 86, No. 34 / Tuesday, February 23, 2021 / Notices 10991 

HIV Immunopathogenesis and Vaccine 

Development Study Section. 

Date: March 18, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Shiv A. Prasad, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5220, 

MSC 7852, Bethesda, MD 20892, 301–443– 

5779, prasads@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

conflict: Musculoskeletal and Skin 

Pathobiology and Regeneration. 

Date: March 18, 2021. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yi-Hsin Liu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1781, liuyh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–HD– 

21–008: Pediatric Biospecimen Procurement 

Center Supporting the Developmental Gene 

Expression (dGTEx) Project (U24). 

Date: March 19, 2021. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kenneth Ryan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3218, 

MSC 7717, Bethesda, MD 20892, 301–435– 

0229, kenneth.ryan@nih.hhs.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Speech, Language, and 

Communication. 

Date: March 19, 2021. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sara Louise Hargrave, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 3170, 

Bethesda, MD 20892, (301) 443–7193, 

hargravesl@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 17, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–03617 Filed 2–22–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; HEAL: Pain Therapeutics 

Development Small Molecule and Biologics. 

Date: March 15, 2021. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Shanta Rajaram, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH, NSC, 6001 Executive Blvd., 

Suite 3208, MSC 9529, Rockville, MD 20852, 

(301) 435–6033, rajarams@mail.nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; P01 Review. 

Date: March 16–19, 2021. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Li Jia, Ph.D., Scientific 

Review Officer, Scientific Review Branch, 

Division of Extramural Research, NINDS/ 

NIH, 6001 Executive Boulevard, Room 

3208D, Rockville, MD 20852, 301–451–2854, 

li.jia@nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Wellstone Centers Review. 

Date: March 18–19, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: W. Ernest Lyons, Ph.D., 

Scientific Review Administrator, Scientific 

Review Branch, NINDS/NIH/DHHS, 

Neuroscience Center, 6001 Executive Blvd., 

Suite 3208, MSC 9529, Rockville, MD 20852, 

301–496–4056, lyonse@ninds.nih.gov. 

Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: February 17, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–03614 Filed 2–22–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Center for Mental Health Services 

National Advisory Council; Notice of 

Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given for the meeting of 

the Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Mental Health Services 

National Advisory Council (CMHS 

NAC) on March 18, 2021. 

The Council was established to advise 

the Secretary, Department of Health and 

Human Services (HHS); the Assistant 

Secretary for Mental Health and 

Substance Use, SAMHSA; and Director, 

CMHS concerning matters relating to 

the activities carried out by and through 

the Center and the policies respecting 

such activities. 

The meeting is open to the public and 

can be accessed remotely only. 

Attendance by the public on-site will 

not be available. The meeting will 

include consideration of the minutes 

from the August 27, 2020, SAMHSA, 

CMHS NAC meeting; updates from the 

CMHS Director; and a discussion from 

the SAMHSA Chief of Staff and the 

Acting Assistant Secretary for Mental 

Health and Substance Use. 

The agenda will be posted on the 

SAMHSA website prior to the meeting 

at: https://www.samhsa.gov/about-us/ 

advisory-councils/meetings. 

Interested persons may present data, 

information, or views, orally or in 

10992 Federal Register / Vol. 86, No. 34 / Tuesday, February 23, 2021 / Notices 

writing, on issues pending before the 

Council. Individuals interested in 

sending written submissions or making 

public comments, must forward them 

to, and notify the contact person on or 

before March 12, 2021. Up to three 

minutes will be allotted for each 

presentation. 

Registration is required to participate 

during this meeting. To attend virtually, 

or to obtain the call-in number and 

access code, submit written or brief oral 

comments, or request special 

accommodations for persons with 

disabilities, please register on-line at: 

http://snacregister.samhsa.gov/ 

MeetingList.aspx, or communicate with 

Pam Foote, Designated Federal Officer 

(DFO). 

Meeting information and a roster of 

Council members may be obtained by 

accessing the SAMHSA website at: 

http://www.samhsa.gov/about-us/ 

advisory-councils/cmhs-nationaladvisory-council, or the DFO. 

Council Name: Substance Abuse and 

Mental Health Services Administration 

Center for Mental Health Services 

National Advisory Council. 

Date/Time/Type: Thursday, March 18, 

2021; 1:00 p.m. to 4:30 p.m., EDT, 

(OPEN). 

Place: SAMHSA, 5600 Fishers Lane, 

Rockville, MD 20857. 

Contact: Pamela Foote, Designated 

Federal Officer (DFO), CMHS National 

Advisory Council, 5600 Fishers Lane, 

Room 14E57B, Rockville, Maryland 

20857, Telephone: (240) 276–1279, Fax: 

(301) 480–8491, Email: pamela.foote@

samhsa.hhs.gov. 

Dated: February 16, 2021. 

Carlos Castillo, 

Committee Management Officer, SAMHSA. 

[FR Doc. 2021–03542 Filed 2–22–21; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Meeting of the Substance Abuse and 

Mental Health Services 

Administration’s National Advisory 

Council 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given of the 

meeting on March 22, 2021, of the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

National Advisory Council (SAMHSA 

NAC). 

The meeting is open to the public and 

can only be accessed virtually. Agenda 

with call-in information will be posted 

on the SAMHSA website prior to the 

meeting at: https://www.samhsa.gov/ 

about-us/advisory-councils/meetings. 

The meeting will include remarks and 

discussion with the Acting Assistant 

Secretary for Mental Health and 

Substance Use; updates on SAMHSA 

priorities, new grant opportunities and 

initiatives, and a council discussion on 

clinical trends and emerging national 

issues with SAMHSA NAC members. 

DATES: March 22, 2021, 1:00 p.m. to 

approximately 5:00 p.m. (ET)/Open. 

ADDRESSES: The meeting will be held 

virtually. 

FOR FURTHER INFORMATION CONTACT: 

Carlos Castillo, Committee Management 

Officer and Designated Federal Official, 

SAMHSA National Advisory Council, 

5600 Fishers Lane, Rockville, Maryland 

20857 (mail), Telephone: (240) 276– 

2787 Email: carlos.castillo@

samhsa.hhs.gov. Valerie Kolick, Acting 

Designated Federal Officer, SAMHSA 

National Advisory Council, 5600 

Fishers Lane, Rockville, Maryland 

20857, Telephone: (240) 276–1738, 

Email: valerie.kolick@samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

SAMHSA NAC was established to 

advise the Secretary, Department of 

Health and Human Services (HHS), and 

the Assistant Secretary for Mental 

Health and Substance Use, SAMHSA, to 

improve the provision of treatments and 

related services to individuals with 

respect to substance use and to improve 

prevention services, promote mental 

health, and protect legal rights of 

individuals with mental illness and 

individuals who are substance users. 

Interested persons may present data, 

information, or views orally or in 

writing, on issues pending before the 

Council. Written submissions must be 

forwarded to the contact person no later 

than seven days before the meeting. Oral 

presentations from the public will be 

scheduled at the conclusion of the 

meeting. Individuals interested in 

making oral presentations must notify 

the contact person by March 12, 2021. 

Up to three minutes will be allotted for 

each presentation, and as time permits. 

To obtain the call-in number, access 

code, and/or web access link; submit 

written or brief oral comments; or 

request special accommodations for 

persons with disabilities, please register 

on-line at: https://

snacregister.samhsa.gov/ 

MeetingList.aspx, or communicate with 

SAMHSA’s Committee Management 

Officer, CAPT Carlos Castillo. 

Meeting information and a roster of 

Council members may be obtained 

either by accessing the SAMHSA 

Council’s website at http://

www.samhsa.gov/about-us/advisorycouncils/, or by contacting Carlos 

Castillo or Valerie Kolick. 

Council Name: Substance Abuse and 

Mental Health Services Administration 

National Advisory Council. 

Authority: Public Law 92–463. 

Dated: February 17, 2021. 

Carlos Castillo, 

Committee Management Officer, SAMHSA. 

[FR Doc. 2021–03573 Filed 2–22–21; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–7034–N–10; OMB Control 

No. 2502–0427] 

30-Day Notice of Proposed Information 

Collection: Mortgagee’s Application for 

Partial Settlement (Multifamily 

Mortgage) 

AGENCY: Office of the Chief Information 

Officer, HUD. 

ACTION: Notice. 

SUMMARY: HUD has submitted the 

proposed information collection 

requirement described below to the 

Office of Management and Budget 

(OMB) for review, in accordance with 

the Paperwork Reduction Act. The 

purpose of this notice is to allow for an 

additional 30 days of public comment. 

DATES: Comments Due Date: March 25, 

2021. 

ADDRESSES: Interested persons are 

invited to submit comments regarding 

this proposal. Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

StartPrintedPage15501PRAMain. Find 

this particular information collection by 

selecting ‘‘Currently under 30-day 

Review—Open for Public Comments’’ or 

by using the search function. 

FOR FURTHER INFORMATION CONTACT: 

Colette Pollard, Reports Management 

Officer, QDAM, Department of Housing 

and Urban Development, 451 7th Street 

SW, Washington, DC 20410; email 

Colette Pollard at Colette.Pollard@

hud.gov or telephone 202–402–3400. 

This is not a toll-free number. Persons 

with hearing or speech impairments 

may access this number through TTY by 

calling the toll-free Federal Relay 

Service at (800) 877–8339. Copies of 

available documents submitted to OMB 

may be obtained from Ms. Pollard.